Strategic realignment powering Bora’s dual-engine businesses model HONG KONG SAR - Media OutReach Newswire - 13 November 2025 - Bora Pharmaceuticals (TWSE: 6472) today ...
Tracking the history of the 3-4-3 — from its defensive origins to the swashbuckling overachievers under Conte, Glasner and ...
SenoCellTec is a next-generation approach for skin rejuvenation that targets the root causes of aging at the cellular level.